位置:首页 > 蛋白库 > TY3H_BOVIN
TY3H_BOVIN
ID   TY3H_BOVIN              Reviewed;         491 AA.
AC   P17289;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   03-AUG-2022, entry version 145.
DE   RecName: Full=Tyrosine 3-monooxygenase;
DE            EC=1.14.16.2 {ECO:0000250|UniProtKB:P07101};
DE   AltName: Full=Tyrosine 3-hydroxylase;
DE            Short=TH;
GN   Name=TH;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2898537; DOI=10.1002/jnr.490190408;
RA   D'Mello S.R., Weisberg E.P., Stachowiak M.K., Turzai L.M., Gioio A.E.,
RA   Kaplan B.B.;
RT   "Isolation and nucleotide sequence of a cDNA clone encoding bovine adrenal
RT   tyrosine hydroxylase: comparative analysis of tyrosine hydroxylase gene
RT   products.";
RL   J. Neurosci. Res. 19:440-449(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2899135; DOI=10.1111/j.1471-4159.1988.tb01077.x;
RA   Saadat S., Stehle A.D., Lamouroux A., Mallet J., Thoenen H.;
RT   "Predicted amino acid sequence of bovine tyrosine hydroxylase and its
RT   similarity to tyrosine hydroxylases from other species.";
RL   J. Neurochem. 51:572-578(1988).
RN   [3]
RP   PROTEIN SEQUENCE OF 154-170.
RX   PubMed=2895648; DOI=10.1016/s0006-291x(88)80524-2;
RA   Abate C., Smith J.A., Joh T.H.;
RT   "Characterization of the catalytic domain of bovine adrenal tyrosine
RT   hydroxylase.";
RL   Biochem. Biophys. Res. Commun. 151:1446-1453(1988).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-28.
RC   TISSUE=Adrenal medulla;
RX   PubMed=2894860; DOI=10.1016/0167-4838(88)90019-2;
RA   Haavik J., Andersson K.K., Petersson L., Flatmark T.;
RT   "Soluble tyrosine hydroxylase (tyrosine 3-monooxygenase) from bovine
RT   adrenal medulla: large-scale purification and physicochemical properties.";
RL   Biochim. Biophys. Acta 953:142-156(1988).
RN   [5]
RP   PHOSPHORYLATION AT SER-19; SER-31 AND SER-40.
RX   PubMed=8096628; DOI=10.1007/bf00966919;
RA   Haycock J.W.;
RT   "Multiple signaling pathways in bovine chromaffin cells regulate tyrosine
RT   hydroxylase phosphorylation at Ser19, Ser31, and Ser40.";
RL   Neurochem. Res. 18:15-26(1993).
CC   -!- FUNCTION: Catalyzes the conversion of L-tyrosine to L-
CC       dihydroxyphenylalanine (L-Dopa), the rate-limiting step in the
CC       biosynthesis of cathecolamines, dopamine, noradrenaline, and
CC       adrenaline. Uses tetrahydrobiopterin and molecular oxygen to convert
CC       tyrosine to L-Dopa (By similarity). In addition to tyrosine, is able to
CC       catalyze the hydroxylation of phenylalanine and tryptophan with lower
CC       specificity (By similarity). Positively regulates the regression of
CC       retinal hyaloid vessels during postnatal development (By similarity).
CC       {ECO:0000250|UniProtKB:P04177, ECO:0000250|UniProtKB:P07101,
CC       ECO:0000250|UniProtKB:P24529}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin + L-tyrosine + O2 =
CC         (4aS,6R)-4a-hydroxy-L-erythro-5,6,7,8-tetrahydrobiopterin + L-dopa;
CC         Xref=Rhea:RHEA:18201, ChEBI:CHEBI:15379, ChEBI:CHEBI:15642,
CC         ChEBI:CHEBI:57504, ChEBI:CHEBI:58315, ChEBI:CHEBI:59560;
CC         EC=1.14.16.2; Evidence={ECO:0000250|UniProtKB:P07101};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18202;
CC         Evidence={ECO:0000250|UniProtKB:P07101};
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000250|UniProtKB:P04177};
CC   -!- ACTIVITY REGULATION: Inhibited in feedback fashion by the catecholamine
CC       neurotransmitters, especially by dopamine in competition with
CC       tetrahydrobiopterin. Phosphorylation of several Ser/Thr residues in the
CC       N-terminus regulates the catalytic activity. Ser-31 and Ser-40 are
CC       readily phosphorylated to activate the catalytic activity. A Cysteine
CC       modification induced by N-ethylmaleimide (NEM), inhibits tyrosine 3-
CC       monooxygenase activity through the modification of the Cys-170.
CC       {ECO:0000250|UniProtKB:P07101}.
CC   -!- PATHWAY: Catecholamine biosynthesis; dopamine biosynthesis; dopamine
CC       from L-tyrosine: step 1/2. {ECO:0000250|UniProtKB:P07101}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Interacts (when phosphorylated
CC       at Ser-19) with YWHAG; one YWHAG dimer bounds to one TH tetramer this
CC       interaction may influence the phosphorylation and dephosphorylation of
CC       other sites (By similarity). {ECO:0000250|UniProtKB:P07101}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:P24529}. Nucleus {ECO:0000250|UniProtKB:P04177}.
CC       Cell projection, axon {ECO:0000250|UniProtKB:P24529}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P04177}. Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle {ECO:0000250|UniProtKB:P04177}. Note=When
CC       phosphorylated at Ser-19 shows a nuclear distribution and when
CC       phsphorylated at Ser-31 as well at Ser-40 shows a cytosolic
CC       distribution (By similarity). Expressed in dopaminergic axons and axon
CC       terminals (By similarity). {ECO:0000250|UniProtKB:P04177,
CC       ECO:0000250|UniProtKB:P07101}.
CC   -!- PTM: Phosphorylated on Ser-19, Ser-31 and Ser-40 by several protein
CC       kinases with different site specificities. Phosphorylation at Ser-31
CC       and Ser-40 leads to an increase of TH activity. Phosphorylation at Ser-
CC       40 activates the enzyme and also counteracts the feedback inhibition of
CC       TH by catecholamines (By similarity). Phosphorylation of Ser-19 and
CC       Ser-31 triggers the proteasomal degradation of TH through the
CC       ubiquitin-proteasome pathway (By similarity). Phosphorylation at Ser-31
CC       facilitates transport of TH from the soma to the nerve terminals via
CC       the microtubule network (By similarity). Phosphorylation at Ser-19
CC       induces the high-affinity binding to the 14-3-3 protein YWHAG; this
CC       interaction may influence the phosphorylation and dephosphorylation of
CC       other sites (By similarity). Ser-19 increases the phosphorylation at
CC       Ser-40 in a hierarchical manner, leading to increased activity (By
CC       similarity). {ECO:0000250|UniProtKB:P04177,
CC       ECO:0000250|UniProtKB:P07101}.
CC   -!- SIMILARITY: Belongs to the biopterin-dependent aromatic amino acid
CC       hydroxylase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M36794; AAA30779.1; -; mRNA.
DR   EMBL; M36705; AAA30798.1; -; mRNA.
DR   PIR; I45983; I45983.
DR   PIR; JL0039; JL0039.
DR   RefSeq; NP_776309.1; NM_173884.2.
DR   AlphaFoldDB; P17289; -.
DR   SMR; P17289; -.
DR   STRING; 9913.ENSBTAP00000038050; -.
DR   BindingDB; P17289; -.
DR   ChEMBL; CHEMBL3713; -.
DR   iPTMnet; P17289; -.
DR   PaxDb; P17289; -.
DR   GeneID; 280707; -.
DR   KEGG; bta:280707; -.
DR   CTD; 7054; -.
DR   eggNOG; KOG3820; Eukaryota.
DR   InParanoid; P17289; -.
DR   OrthoDB; 614557at2759; -.
DR   SABIO-RK; P17289; -.
DR   UniPathway; UPA00747; UER00733.
DR   PRO; PR:P17289; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004511; F:tyrosine 3-monooxygenase activity; IBA:GO_Central.
DR   GO; GO:0006585; P:dopamine biosynthetic process from tyrosine; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; IBA:GO_Central.
DR   GO; GO:1990384; P:hyaloid vascular plexus regression; ISS:UniProtKB.
DR   GO; GO:0042136; P:neurotransmitter biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0045471; P:response to ethanol; IBA:GO_Central.
DR   GO; GO:0001666; P:response to hypoxia; IBA:GO_Central.
DR   CDD; cd03345; eu_TyrOH; 1.
DR   Gene3D; 1.10.800.10; -; 1.
DR   InterPro; IPR045865; ACT-like_dom_sf.
DR   InterPro; IPR001273; ArAA_hydroxylase.
DR   InterPro; IPR036951; ArAA_hydroxylase_sf.
DR   InterPro; IPR036329; Aro-AA_hydroxylase_C_sf.
DR   InterPro; IPR019774; Aromatic-AA_hydroxylase_C.
DR   InterPro; IPR041903; Eu_TyrOH_cat.
DR   InterPro; IPR005962; Tyr_3_mOase.
DR   InterPro; IPR019773; Tyrosine_3-monooxygenase-like.
DR   InterPro; IPR021164; Tyrosine_hydroxylase_CS.
DR   PANTHER; PTHR11473; PTHR11473; 1.
DR   Pfam; PF00351; Biopterin_H; 1.
DR   Pfam; PF12549; TOH_N; 2.
DR   PIRSF; PIRSF000336; TH; 1.
DR   PRINTS; PR00372; FYWHYDRXLASE.
DR   SUPFAM; SSF55021; SSF55021; 1.
DR   SUPFAM; SSF56534; SSF56534; 1.
DR   TIGRFAMs; TIGR01269; Tyr_3_monoox; 1.
DR   PROSITE; PS51410; BH4_AAA_HYDROXYL_2; 1.
PE   1: Evidence at protein level;
KW   Catecholamine biosynthesis; Cell projection; Cytoplasm;
KW   Cytoplasmic vesicle; Direct protein sequencing; Iron; Metal-binding;
KW   Monooxygenase; Neurotransmitter biosynthesis; Nucleus; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; Synapse.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2894860"
FT   CHAIN           2..491
FT                   /note="Tyrosine 3-monooxygenase"
FT                   /id="PRO_0000205560"
FT   BINDING         324
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:P04177"
FT   BINDING         329
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:P04177"
FT   BINDING         369
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000250|UniProtKB:P04177"
FT   SITE            418
FT                   /note="Important for substrate specificity"
FT                   /evidence="ECO:0000250|UniProtKB:P04177"
FT   MOD_RES         19
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000269|PubMed:8096628"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8096628"
FT   MOD_RES         40
FT                   /note="Phosphoserine; by CaMK2 and PKA"
FT                   /evidence="ECO:0000269|PubMed:8096628"
FT   MOD_RES         465
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P24529"
FT   CONFLICT        65..68
FT                   /note="AAWL -> GSLV (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        73
FT                   /note="E -> K (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        83
FT                   /note="P -> R (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        86
FT                   /note="R -> K (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        284
FT                   /note="A -> V (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        321
FT                   /note="E -> D (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        328..330
FT                   /note="GHV -> AHG (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        380
FT                   /note="K -> N (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        471
FT                   /note="H -> R (in Ref. 2; AAA30798)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   491 AA;  55123 MW;  86707712238F12F2 CRC64;
     MPTPNAASPQ AKGFRRAVSE LDAKQAEAIM SPRFVGRRQS LIQDARKERE KAEAAASSSE
     SAEAAAWLER DGEAVLTLLF ALPPTRPPAL TRAIKVFETF EAHLHHLETR PAQPLRAGSP
     PLECFVRCEV PGPVVPALLS ALRRVAEDVR AAGESKVLWF PRKVSELDKC HHLVTKFDPD
     LDLDHPGFSD QAYRQRRKLI AEIAFQYKQG DPIPHVEYTA EETATWKEVY STLRGLYPTH
     ACREHLEAFE LLERFCGYRE DRIPQLEDVS RFLKERTGFQ LRPAAGLLSA RDFLASLAFR
     VFQCTQYIRH ASSPMHSPEP ECCHELLGHV PMLADRTFAQ FSQDIGLASL GVSDEEIEKL
     STLYWFTVEF GLCKQNGEVK AYGAGLLSSY GELLHSLSEE PEIRAFDPDA AAVQPYQDQT
     YQPVYFVSES FSDAKDKLRS YASRIQRPFS VKFDPYTLAI DVLDSPHAIR HALDGVQDEM
     QALAHALNAI S
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024